Study title: MRL Clinical Study Report: An Open, Two-Period Crossover Study to Determine the Relative Bioavailability of Lisinopril Suspension 20 mg and Marketed PRINIVILâ„¢ 20-mg Tablets (Protocol 037).
| Type of medicine: Medicines containing chemical active substances | |||||
| Therapeutic area: Cardiovascular Diseases | |||||
| Brands: Please see report | |||||
| MAH holders: Please see report | |||||
| Assessment: | |||||
| Active substance: LISINOPRIL | |||||
| ATC code: C 09 AA 03 | |||||
| Document link: | |||||
| Document date: | |||||
| Study number: | |||||
| EudraCT number: | |||||
| Scope of study: Clinical | |||||
| Population of study subjects: | Preterm newborn Infants | Newborn infants (1 to 27 days) | Infants and toddlers (28 days to 24 months) | Children (2 to 11 years) | Adolescents (12 to 18 years) |
| - | - | - | Y | Y | |